Committees

Organizing Committee - Industry Liaison


Organizing Committee

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They come together on a frequent basis to discuss the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts. 


Industry Liaison

The members of Industry Liaison Committee assist in inviting industry professionals working in the field to join the event and/or the program.

Dinesh de Alwis, PhD - Merck Research Labs 
Barbara Brennan - Roche
Elisabeth Rouits, PharmD, PhD - Debiopharm
Rene Bruno, PhD - Genentech
Owen Jones, PhD - Astra Zeneca
Bart Ploeger - Bayer

Back to top

Committees

Organizing Committee - Scientific Committee


Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Back to top


Scientific Committee

The members of Scientific Committee assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee actively participate in reviewing submitted abstracts.

Jan-Willem Alffenaar, PhD, PharmD UMCG, The Netherlands
Deron Burton
CDC, USA
Dakshina Chilukuri, PhD FDA, USA
Véronique Dartois, PhD Rutgers, The State University of New Jersey, Newark, USA
Paolo Denti, PhD University of Cape Town, South Africa
Kelly Dooley, MD, PhD Johns Hopkins University, USA
Tawanda Gumbo, MD Baylor Institute for Immunology Research, USA
Richard Hafner, MD National Institutes of Health, USA
Scott Heysell, MD, MPH University of Virginia, USA
Anneke Hesseling, MD Desmond Tutu Tuberculosis Centre, South Africa
Russell Kempker, MD, MSc Emory University School of Medicine, USA
Steven Kern, PhD Bill & Melinda Gates Foundation, USA
Christian Lienhardt, MD, PhD WHO – Stop TB Department, Switzerland
Khisi Mdluli, PhD Global Alliance for TB Drug Development, USA
Rovina Ruslami, MD, PhD Padjadjaran University, Indonesia
Ulrika Simonsson, PharmD, PhD Uppsala University, Sweden
Susan Swindells, MBBS University of Nebraska Medical Center, USA
Andrew Vernon, MD CDC, TBTC, USA
Robert Wallis, MD, FIDSA The Aurum Institute, South Africa

Back to top

Committees

Organizing Committee

The members of the Organizing Committee (OC) discuss on a frequent basis the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific programme of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Organizing Committee

Jan Albert, MD - Chair 2013 Charles Boucher, MD, PhD Myron Cohen MD Walid Heneine, PhD Thomas Hope, PhD Eric Hunter, PhD Phyllis Kanki,DVM, DSc Bonnie Mathieson, PhD Gabriella Scarlatti, MD, PhD Ron Swanstrom, PhD Mark Wainberg, MD, PhD - Chair 2013 Annemarie Wensing, MD, PhD Bonaventura Clotet, MD, PhD - Guest Chair 2013 The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.